Status: Recruiting
SURGE: Supporting Utility and Representation in Genomics-based Cancer Trial Enrollment (Intervention)
SURGE aims to increase representation in clinical trial enrollment by addressing barriers to genomic testing, which is increasingly needed to assess precision clinical trial eligibility and access standard precision therapies. The study is an interventional pilot meant primarily to assess the feasibility of the intervention. The intervention is comprised of a patient navigator, text message questionnaire, and informational video.
Participants needed: 210
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Nadine Jackson, MD, MPHUpdated: Sep 16, 2026Locations: 3
Eligibility criteria
Adult (age 18 years or older) [+3]
Malignancy or former malignancy that requires only surveillance [+3]